Ribosome-component immune modulation of respiratory tract infections in children

Allergy and Asthma Proceedings

Volumn 30, Issue 4 SUPPL. 1, 2009, Pages

  Fiocchi, Alessandro ^a   Terracciano, Luigi ^a   Martelli, Alberto ^a   Bernardo, Luca ^a   Calcinai, Elena ^a   Marcassa, Sergio ^b  

^a Melloni University Hospital   (Italy)

^b Medical Marketing Department   (Italy)

Author keywords

Antibiotic treatment; Bacterial extracts; Bronchospasm; Children; ENT; Immune modulators; Prevention; Recurrent respiratory infections (RRIs); Ribosomal fractions; Ribosome component immune modulator (RCIM)

Indexed keywords

BACTERIUM LYSATE; IMMUNOMODULATING AGENT; PIDOTIMOD; PLACEBO; PLANT EXTRACT; PROPOLIS; RIBOMUNYL; RIBOSOME COMPONENT IMMUNE MODULATOR; UNCLASSIFIED DRUG;

ARTICLE; ASTHMA; ATOPIC DERMATITIS; BACTERIUM; BRONCHOSPASM; CHILD CARE; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG ERUPTION; DRUG FEVER; EAR NOSE THROAT DISEASE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOSTIMULATION; NAUSEA; OTORHINOLARYNGOLOGICAL INFECTION; PATHOGENESIS; RECURRENT DISEASE; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; UPPER RESPIRATORY TRACT INFECTION; WORKPLACE;

ANTIGENS, BACTERIAL; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; DRUG THERAPY; HUMANS; IMMUNOLOGIC FACTORS; INCIDENCE; INFANT; ITALY; OTITIS MEDIA; RECURRENCE; RESPIRATORY TRACT INFECTIONS; SINUSITIS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME;

EID: 68949091873     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2009.30.3248     Document Type: Article

References (75)

1. McCutcheon H, and Fitzgerald M. The public health problem of acute respiratory illness in children. J Clin Nurs 10:305-310, 2001. (Pubitemid 33754754)
2. Paradise JL, Rockette HE, Colbutn DK, et al. Otitis media in 2253 Pittsburg-area infants: Prevalence and risk factors during the first two years of life. Pediatrics 99:318-335, 1997.
3. Teele DW, Klein JO, Rosner B, et al. Epidemiology of otitis media during the first seven years of life in children in greater Boston: A prospective, cohort study. J Infect Dis 160:83-94, 1989. (Pubitemid 19162997)
4. Wald ER, Guerra N, and Byers C. Upper respiratory tract infections in young children: Duration of and frequency of complications. Pediatrics 87:129-133, 1991.
5. Wald ER. Sinusitis in infants and children. Ann Otol Rhinol Laryngol 155:37-41, 1992.
6. Bhave SY. Approach to recurrent respiratory infections. Indian J Pediatr 68:26-32, 2000.
7. Brook I, and Gobler AE. Dynamics of nasopharyngitis in children. Otolaryngol Head Neck Surg 122:696-700, 2000.
8. International Rhinitis Management Working Group. International Consensus Report on the diagnosis and management of rhinitis. Allergy 49:1-34, 1994.
9. Graham NM. The epidemiology of acute respiratory infections in children and adults: A global perspective. Epidemiol Rev 12:149-178, 1990.
10. De Martino M, and Vierucci A. Il bambino con infezioni respiratorie ricorrenti. Immunol Pediatr 1:76-79, 1981.
11. Bellanti JA. Recurrent respiratory tract infections in paediatric patients. Drugs 54:1-4, 1997. (Pubitemid 27417390)
12. Howel D, Webster S, Hayes J, et al. The impact of recurrent throat infection on children and their families. Fam Pract 19: 242-246, 2002. (Pubitemid 34567647)
13. Leder K. Respiratory illness during winter: A cohort study of urban children from temperate Australia. J Paediatr Child Health 41:125-129, 2005.
14. Brook I, and Shak K. Bacteriology of adenoids and tonsils in children with recurrent adenotonsillitis. Ann Otol Rhinol Laryngol 110:844-848, 2001. (Pubitemid 32845731)
15. Gehanno P, Barry B, Bingen E, et al. Microbiology of otitis media in the Paris, France, area from 1987 to 1997. Pediatr Infect Dis J 20:570-573, 2001.
16. Volkov IK, Katosova LK, Shcherbakova NI, et al. Moraxella catarrhalis in chronic and relapsing respiratory tract infections in children. Antibiot Khimioter 49:43-47, 2004.
17. Nokso-Koivisto J, Hovi T, and Pitkaranta A. Viral upper respiratory tract infections in young children with emphasis on acute otitis media. Int J Pediatr Otorhinolaryngol 70:1333-1342, 2006. (Pubitemid 43866935)
18. Chantry CJ, Howard CR, and Auinger P. Full breastfeeding duration and associated decrease in respiratory tract infection in US children. Pediatrics 117:425-432, 2006. (Pubitemid 46071605)
19. Trosini-Desert V, Germaud P, and Dautzenberg B. Tobacco smoke and risk of bacterial infection. Rev Mal Respir 21:539-554, 2004. (Pubitemid 38969393)
20. Soderstrom M. Respiratory tract infections in children with recurrent episodes as preschoolers. Acta Paediatr Scand 80:688-695, 1991.
21. Rovers MM, Balemas WA, Sanders EA, et al. Persistence of upper respiratory tract infections in a cohort followed from childhood to adults. Fam Pract 23:286-290, 2006.
22. Ciprandi G, Tosca MA, and Fasce L. Allergic children have more numerous and severe respiratory infections than nonallergic children. Pediatr Allergy Immunol 17:389-391, 2006. (Pubitemid 43989963)
23. Karevold G, Kvestad E, Nafstad P, et al. Respiratory infections in schoolchildren: Co-morbidity and risk factors. Arch Dis Child 91:391-1339, 2006. (Pubitemid 43672363)
24. Costa Carvalho BT, Nagao AT, Arslanian C, et al. Immunological evaluation of allergic respiratory children with recurrent sinusitis. Pediatr Allergy Immunol 16:534-538, 2005. (Pubitemid 41414997)
25. Pitkaranta A, Kolho KL, and Rautelin H. Helicobacter pylori in children who are prone to upper respiratory tract infections. Arch Otolaryngol Head Neck Surg 131:256-258, 2005.
26. Van Zeijl JH, Mullaart RA, Borm GF, et al. Recurrence of febrile seizures in the respiratory season is associated with influenza A. J Pediatr 145:800-805, 2004.
27. Kubba H, Swan IR, and Gatehouse S. Measuring quality of life in preschool children with sore throats and otitis media using the TAPQOL questionnaire. Otolaryngol Head Neck Surg 132: 647-652, 2005. (Pubitemid 40460900)
28. Cohen R, Just J, Koskas M, et al. Recurrent respiratory tract infections: How should we investigate and treat? Arch Pediatr 12:183-190, 2005.
29. Posfay Barbe KM, Barazzone-Argiroffo C, and Siegrist CA. Recurrent lower respiratory tract infection in children: When and how should they be investigated? Rev Med Suisse 1:493-498, 2005.
30. de Vries E. Immunological investigations in children with recurrent respiratory infections. Paediatr Respir Rev 2:32-36, 2001. (Pubitemid 32454717)
31. Copenhaver CC, Gern JE, Li Z, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 170:175-180, 2004. (Pubitemid 38925164)
32. Daele J, and Zicot AF. Humoral immunodeficiency in recurrent upper respiratory tract infections. Some basic, clinical and therapeutic features. Acta Otorhinolaryngol Belg 54:373-390, 2000.
33. Copenhaver CC, Gern JE, Li Z, Shult PA, et al. Cytokine response patterns, exposure to viruses, and respiratory infections in the first year of life. Am J Respir Crit Care Med 170:175-180, 2004. (Pubitemid 38925164)
34. Malaponte G, Bevelacqua V, Li Volti G, et al. Soluble adhesion molecules and cytokines in children affected by recurrent infections of the upper respiratory tract. Pediatr Res 55:666-673, 2004. (Pubitemid 38405855)
35. Ozkan H, Atlihan F, Genel F, et al. IgA and/or IgG subclass deficiency in children with recurrent respiratory infections and its relationship with chronic pulmonary damage. J Investig Allergol Clin Immunol 15:69-74, 2005. (Pubitemid 40547635)
36. Cemek M, Dede S, Bayiroglu F, et al. Oxidant and antioxidant levels in children with acute otitis media and tonsillitis: A comparative study. Int J Pediatr Otorhinolaryngol 69:823-827, 2005. (Pubitemid 40693232)
37. Libon C, Haeuw JF, Crouzet F, et al. Streptococcus pneumoniae polysaccharides conjugated to the outer membrane protein A from Klebsiella pneumoniae elicit protective antibodies. Vaccine 20:2174-2180, 2002.
38. Cruise A. Tonsillar size is an important indicator of recurrent acute tonsillitis. Clin Otolaryngol 30:211-212, 2005.
39. Berber A, and Del-Rio-Navarro B. Compilation and meta-analysis of randomized placebo-controlled clinical trials on the prevention of respiratory tract infections in children using immunostimulants. J Investig Allergol Clin Immunol 11:235-246, 2001. (Pubitemid 34230130)
40. Del-Rio-Navarro BE, Espinosa R, Flenady V, and Sienra-Monge JJ. Immunostimulants for preventing respiratory tract infection in children. Cochrane Database Syst Rev 18:CD004974, 2006. (Pubitemid 46841223)
41. Kligler B. Echinacea. Am Fam Physician 67:77-80, 2003.
42. Carr RR, and Nahata MC. Complementary and alternative medicine for upper-respiratory-tract infection in children. Am J Health Syst Pharm 63:33-39, 2006. (Pubitemid 43062528)
43. Taylor JA, Webber W, Standish L, et al. Efficacy and safety of Echinacea in treating upper respiratory tract infections in children: A randomized controlled trial. JAMA 290:2824-2830, 2003. (Pubitemid 37509490)
44. Cohen HA, Varsano I, Kahan E, et al. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: A randomized, double-blind, placebo-controlled, multicenter study. Arch Pediatr Adolesc Med 158:217-221, 2004. (Pubitemid 38282403)
45. Burgio GR, Marseglia GL, Severi F, et al. Immunoactivation by pidotimod in children with recurrent respiratory infections. Arzneimittelforsch 44:1525-1529, 1994.
46. Boccaccio C, Jacod S, Kaiser A, et al. Identification of a clinical-grade maturation factor for dendritic cells. J Immunother 25: 88-96, 2002. (Pubitemid 34052839)
47. Jongmans W, Tiemessen DM, van Vlodrop IJH, et al. Th1-polarising capacity of clinical-grade dendritic cells is triggered by Ribomunyl but is compromised by PGE2. J Immunother 28:480-487, 2005.
48. Youmans AS, and Youmans GP. Immunogenic activity of a ribosomal fraction obtained from Mycobacterium tuberculosis. J Bacteriol 89:1291-1298, 1965.
49. Nikolaeva LV, and Savelev EP. Molecular-biological and immunological properties of ribosomal vaccines. Biomed Sci 2:1-10, 1991.
50. Levenson VJ, Mallett CP, and Hale TL. Protection against local Shigella sonnei infection in mice by parenteral immunization with a nucleoprotein subcellular vaccine. Infect Immun 63:2762-2765, 1995.
51. Faure GC, Béné MC, Simon C, et al. Increase in specific antibody-forming cells in human tonsils after oral stimulation with D-53, a ribosomal vaccine. Int J Immunopharmacol 12:315-320, 1990. (Pubitemid 20111665)
52. Zanin C, Perrin P, Bene MC, et al. Antibody-producing cells in peripheral blood and tonsils after oral treatment of children with bacterial ribosomes. Int J Immunopharmacol 16:497-505, 1994. (Pubitemid 24193264)
53. Faure G, and Béné MC. Use of bacterial ribosomal immunostimulators in respiratory tract infections. Clin Immunother 4:138-146, 1995.
54. Kolopp-Sarda MN, Bene ME, Allaire JM, et al. Kinetics of specific salivary IgA responses in man after oral challenge by ribosomal immunostimulant. Int J Immunopharmacol 19:181-186, 1997.
55. Spisek R, Brazova J, Rozkova D, et al. Maturation of dendritic cells by baterial immunomodulators. Vaccine 22:2761-2768, 2004. (Pubitemid 38900652)
56. Portales P, and Clot J. Immunostimulants revisited: Focus on the pharmacology of Immucytal. BioDrugs 20:81-84, 2006.
57. Bellanti JA, Olivieri D, and Seranno E. Ribosomal immunostimulation: A review evaluating its clinical relevance in prevention of upper and lower respiratory tract infections in children and adults. BioDrugs 17:355-367, 2003. (Pubitemid 37271866)
58. Traissac L, and Petit J. Traitment préventif des infections OPL récidivantes par Ribomunyl comprimé. Immunologie Médicale 16:52-54, 1986.
59. Hüls G, Hirche H, and Lindemann H. Klinische Effizienz eines neuen multibakteriellen Immuntherapeutikums (Ribomunyl) bei Kindern und Jugendlichen mit rezidivierenden respiratorischen Infekten. Jatros Pädiatris 7:3-13, 1991.
60. Perruchet AM. Bilan épidémiologique de l'otite séromuqueuse chez 458bORL français. Rev Soc Fr ORL 7:59-62, 1991.
61. Menardo JL, and Perruchet AM. Epidemiologic and Therapeutic Survey Prevention of Respiratory Infections Among Children with Respiratory Allergy. Clin Exp Allergy 20:127, 1990.
62. Hofman J, Botulinska E, Stasiak-Barmuta A, et al. The effect of bacterial ribosomes extract on clinical and immunological parameters in children with recurrent infections of respiratory tract with bronchospastic symptoms. XXI Congress of the European Academy of Allergology and Clinical Immunology, Napoli, 2002. Allergy 57(Suppl 73), 2002, Abstract 616.
63. Castaneda NJL, and Chavez RR. Estudio de eficacia de un tratamiento preventive de 3 meses de duracion con derivados ribosomales en ninos con infecciones respiratoria recurrente que asisten a guarderia. Revi Enfermed Infeccionas Pediatr 15:121-126, 2002.
64. Mira E, and Benazzo M. Ruolo di un preparato immunostimolante costituito da frazioni ribosomali batteriche e da proteoglicani di membrana di K. Pneumoniae nella prevenzione delle infezioni respiratorie e otorinolaringoiatriche. J Clin Med 1:1-15, 2003.
65. Spicak V. Overall summary on clinical efficacy with Ribomunyl. Pediatr Res 45:749, 1999.
66. Giovannini M, Fiocchi A, Sala M, et al. Immucytal in the prevention and treatment of recurrent upper respiratory tract infections in children: A randomized, placebo-controlled, doubleblind study. Int J Immunother 16:67-75, 2000. (Pubitemid 32294088)
67. Mora R, Barbieri M, Passali GC, et al. A preventive measure for otitis media in children with upper respiratory tract infections. J Pediatr Otorhinolaryngol 63:111-118, 2002. (Pubitemid 34296511)
68. Mora R, Ralli G, Passali FM, et al. Short ribosomal prophylaxis in the prevention of clinical recurrences of chronic otitis media in children. Int J Pediatr Otorhinolaryngol 68:83-89, 2004.
69. Mora R, Dellepiane M, Crippa B, et al. Ribosomal therapy in the prophylaxis of recurrent pharyngotonsillitis in children. Int J of Pediatr Otorhinolaryngol 71:257-261, 2007. (Pubitemid 46075151)
70. Brunetti L, Francavilla R, Tesse R, et al. Effects of oral bacterial immunotherapy in children with atopic eczema/dermatitis syndrome: A pilot study. BioDrugs 19:393-399, 2005. (Pubitemid 43060722)
71. Elies W, and Pletan Y. An International medico-economic survey of 2007 children with recurrent nasopharyngitis and acute otitis media. Drugs 54:5-12, 1997.
72. Banz K, Schwicker D, and Thomas AM. Economic evaluation of immunoprophylaxis in children with recurrent ear, nose and throat infections. Pharmacoeconomics 6:464-477, 1994.
73. Banz K, Thomas AM, and Olivieri D. Economic evaluation of ribosomal immunotherapy in patients with chronic ear, nose and throat and respiratory tract infections: Results for Italy. BioDrugs 10:385-396, 1998. (Pubitemid 28525335)
74. Berdeaux G, Lafuma A, Perruchet AM, et al. Cost effectiveness of immunoprophylaxis in the prevention of recurrent infectious rhinitis in adults. Pharmacoeconomics 14:313-322, 1998. (Pubitemid 28416934)
75. Van Cauwenberge P, Bordeaux G, Morineau A, et al for the Rhinitis Survey Group. Use of Diagnostic clusters to assess the economic consequences of rhynopharyngitis in children in Italy and France during the winter. Clin Ther 21:404-421, 1999.